Good morning :)
Coral Laboratories Ltd

Coral Laboratories Ltd

CORALAB Share Price

BSE
₹362.054.99% (-19.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹142 cr, stock is ranked 2,706

High Risk

Stock is 3.16x as volatile as Nifty

CORALAB Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹142 cr, stock is ranked 2,706

High Risk

Stock is 3.16x as volatile as Nifty

CORALAB Performance & Key Metrics

CORALAB Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
10.210.71—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
34.795.490.61%

CORALAB Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

CORALAB Company Profile

The Company is engaged in the pharmaceutical business. The Company offers products in various categories like sterile, non sterile, nutraceutical and otc products catering to lifestyle segment.

CORALAB Similar Stocks (Peers)

Compare with peers Compare with peers 

CORALAB Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
38.60
38.60
1Y Return
3.59%
3.59%
Buy Reco %
94.12
94.12
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
74.62
74.62
1Y Return
31.93%
31.93%
Buy Reco %
81.48
81.48
Lupin Ltd
LUPIN
PE Ratio
31.99
31.99
1Y Return
15.65%
15.65%
Buy Reco %
72.22
72.22
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
18.45
18.45
1Y Return
10.28%
10.28%
Buy Reco %
51.61
51.61
Cipla Ltd
CIPLA
PE Ratio
18.72
18.72
1Y Return
16.22%
16.22%
Buy Reco %
51.61
51.61
Compare with Peers

CORALAB Forecast

CORALAB Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

CORALAB

CORALAB

Income

Balance Sheet

Cash Flow

CORALAB Income Statement

CORALAB Income Statement

Loading...

Quartersep 2023dec 2023mar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025
Total Revenue24.9619.5230.9833.2234.7725.5130.6220.8722.0724.06
Operating & Other expensessubtract17.0016.0522.7320.9225.7216.6726.2216.6414.1019.67
Depreciation/Amortizationsubtract0.440.490.500.490.510.500.510.450.450.69
Interest & Other Itemssubtract0.000.000.000.030.010.020.040.060.100.00
Taxes & Other Itemssubtract1.520.821.952.972.152.171.021.161.600.92
EPS16.816.0416.2024.6417.8617.207.917.1816.297.77
See Costs

EPS in ₹. Other numbers in ₹ cr

CORALAB Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

CORALAB Stock Peers

CORALAB Past Performance & Peer Comparison

CORALAB Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Coral Laboratories Ltd5.910.71—
Sun Pharmaceutical Industries Ltd38.605.820.91%
Torrent Pharmaceuticals Ltd74.6218.790.76%
Lupin Ltd31.996.070.52%

CORALAB Stock Price Comparison

Compare CORALAB with any stock or ETF
Compare CORALAB with any stock or ETF
CORALAB
Loading...

CORALAB Holdings

CORALAB Shareholdings

CORALAB Promoter Holdings Trend

CORALAB Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

CORALAB Institutional Holdings Trend

CORALAB Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

CORALAB Shareholding Pattern

CORALAB Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding71.51%0.00%0.00%0.00%28.49%

Mar 2025

Jun 2025

Sep 2025

Dec 2025

CORALAB Shareholding History

CORALAB Shareholding History

SepDec '24MarJunSepDec '250.00%0.00%0.00%0.00%0.00%0.00%

CORALAB Insider Trades & Bulk Stock Deals

CORALAB Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing CORALAB stock

smallcases containing CORALAB stock

Looks like this stock is not in any smallcase yet.

CORALAB Events

CORALAB Events

CORALAB Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

CORALAB has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

CORALAB Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

CORALAB has not given any dividends in last 5 years

CORALAB Upcoming Dividends

CORALAB Upcoming Dividends

No upcoming dividends are available

CORALAB Past Dividends

CORALAB Past Dividends

Cash Dividend

Ex DateEx DateSep 19, 2025

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Sep 19, 2025

Cash Dividend

Ex DateEx DateSep 20, 2024

Final
Final | Div/Share: ₹2.00

Dividend/Share

₹2.00

Ex DateEx Date

Sep 20, 2024

Cash Dividend

Ex DateEx DateSep 19, 2019

Final
Final | Div/Share: ₹2.00

Dividend/Share

₹2.00

Ex DateEx Date

Sep 19, 2019

Cash Dividend

Ex DateEx DateSep 18, 2018

Final
Final | Div/Share: ₹2.00

Dividend/Share

₹2.00

Ex DateEx Date

Sep 18, 2018

Cash Dividend

Ex DateEx DateSep 11, 2017

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Sep 11, 2017

CORALAB Stock News & Opinions

CORALAB Stock News & Opinions

Earnings
Coral Laboratories standalone net profit declines 54.72% in the December 2025 quarter

Net profit of Coral Laboratories declined 54.72% to Rs 2.78 crore in the quarter ended December 2025 as against Rs 6.14 crore during the previous quarter ended December 2024. Sales declined 6.22% to Rs 21.56 crore in the quarter ended December 2025 as against Rs 22.99 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales21.5622.99 -6 OPM %8.8127.45 - PBDT4.398.81 -50 PBT3.708.31 -55 NP2.786.14 -55 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Coral Laboratories to convene board meeting

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Coral Laboratories standalone net profit declines 8.78% in the September 2025 quarter

Net profit of Coral Laboratories declined 8.78% to Rs 5.82 crore in the quarter ended September 2025 as against Rs 6.38 crore during the previous quarter ended September 2024. Sales declined 40.96% to Rs 19.03 crore in the quarter ended September 2025 as against Rs 32.23 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales19.0332.23 -41 OPM %25.9620.20 - PBDT7.559.04 -16 PBT7.108.53 -17 NP5.826.38 -9 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Coral Laboratories to announce Quarterly Result

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Coral Laboratories to hold board meeting

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 25 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Coral Laboratories schedules AGM

Coral Laboratories announced that the 43th Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Coral Laboratories standalone net profit declines 70.91% in the June 2025 quarter

Net profit of Coral Laboratories declined 70.91% to Rs 2.56 crore in the quarter ended June 2025 as against Rs 8.80 crore during the previous quarter ended June 2024. Sales declined 40.56% to Rs 18.82 crore in the quarter ended June 2025 as against Rs 31.66 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales18.8231.66 -41 OPM %11.5833.89 - PBDT4.1712.26 -66 PBT3.7211.77 -68 NP2.568.80 -71 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Coral Laboratories to convene board meeting

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Board of Coral Laboratories recommends final dividend

Coral Laboratories announced that the Board of Directors of the Company at its meeting held on 30 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.Powered by Capital Market - Live

9 months agoCapital Market - Live
Earnings
Coral Laboratories standalone net profit declines 51.12% in the March 2025 quarter

Net profit of Coral Laboratories declined 51.12% to Rs 2.83 crore in the quarter ended March 2025 as against Rs 5.79 crore during the previous quarter ended March 2024. Sales declined 2.63% to Rs 28.13 crore in the quarter ended March 2025 as against Rs 28.89 crore during the previous quarter ended March 2024. For the full year,net profit rose 53.01% to Rs 24.16 crore in the year ended March 2025 as against Rs 15.79 crore during the previous year ended March 2024. Sales rose 37.47% to Rs 115.01 crore in the year ended March 2025 as against Rs 83.66 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales28.1328.89 -3 115.0183.66 37 OPM %9.5621.60 -22.8219.41 - PBDT5.138.33 -38 35.2522.87 54 PBT4.627.83 -41 33.2420.89 59 NP2.835.79 -51 24.1615.79 53 Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Coral Laboratories Ltd (CORALAB) today?

    The share price of CORALAB as on 27th March 2026 is ₹362.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Coral Laboratories Ltd (CORALAB) share?

    The past returns of Coral Laboratories Ltd (CORALAB) share are
    • Past 1 week: -18.23%
    • Past 1 month: -18.33%
    • Past 3 months: -19.87%
    • Past 6 months: -27.56%
    • Past 1 year: -48.82%
    • Past 3 years: 63.79%
    • Past 5 years: 12.19%

  3. What are the peers or stocks similar to Coral Laboratories Ltd (CORALAB)?

    The peers or stocks similar to Coral Laboratories Ltd (CORALAB) include:

  4. What is the market cap of Coral Laboratories Ltd (CORALAB) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Coral Laboratories Ltd (CORALAB) is ₹142.90 Cr as of 27th March 2026.

  5. What is the 52 week high and low of Coral Laboratories Ltd (CORALAB) share?

    The 52-week high of Coral Laboratories Ltd (CORALAB) is ₹784.55 and the 52-week low is ₹360.

  6. What is the PE and PB ratio of Coral Laboratories Ltd (CORALAB) stock?

    The P/E (price-to-earnings) ratio of Coral Laboratories Ltd (CORALAB) is 5.91. The P/B (price-to-book) ratio is 0.71.

  7. Which sector does Coral Laboratories Ltd (CORALAB) belong to?

    Coral Laboratories Ltd (CORALAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Coral Laboratories Ltd (CORALAB) shares?

    You can directly buy Coral Laboratories Ltd (CORALAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.